Voices

Aug 24, 2025, 15:26

IASLC Congratulates Pedro Rocha: 2025 Young Investigator Awardee for SCLC Biomarker Research

International Association for the Study of Lung Cancer shared on LinkedIn:

“Congrats to Dr. Pedro Rocha, Medical Oncologist at Vall d’Hebron University Hospital! One of our 2025 Young Investigator Awardees!

Their project, Sex-Based Biomarkers and Molecular Profiles as Predictors of BiTEs Therapy Response in Small Cell Lung Cancer, explores sex-specific biomarkers of response to BiTE therapy in ES-SCLC. Using blood and tissue samples from our biobank, they will apply single-cell RNA and T-cell receptor sequencing to track immune changes during treatment, aiming to explain observed sex-based differences in efficacy and guide personalized therapy.

We’re excited to see where this research leads, way to go, Dr. Rocha!”

Pedro Rocha

More posts featuring IASLC.

2025 Young Investigator Awardee cancer IASLC International Association for the Study of Lung Cancer Lung cancer OncoDaily Oncology SCLC Biomarker Research

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Writer?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...